Furthermore, functional studies have demonstrated that the overexpression of KRT17P3 in cultured NSCLC cells improves cell viability and decreases apoptosis after cisplatin treatment, both in vitro and in vivo.128. The gene discussed is KRT17P3; the disease is non-small cell lung carcinoma.